# Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals

Study · id `cardio:ct-nct02472028` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02472028](<https://clinicaltrials.gov/study/NCT02472028>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02472028

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 820 participants.

## Technical summary

Registry record NCT02472028. Randomized; no masking; primary purpose prevention. Start 2015-09 (actual); primary completion 2028-09-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 820 participants (planned count; ClinicalTrials.gov record NCT02472028, source copy `cardio:ctgov-nct02472028-2026-10-29`, retrieved 2026-10-31)
- Started: 2015-09 (actual) (ClinicalTrials.gov record NCT02472028, source copy `cardio:ctgov-nct02472028-2026-10-29`, retrieved 2026-10-31)
- Primary completion: 2028-09-11 (anticipated) (ClinicalTrials.gov record NCT02472028, source copy `cardio:ctgov-nct02472028-2026-10-29`, retrieved 2026-10-31)
- Completion: 2028-09-11 (anticipated) (ClinicalTrials.gov record NCT02472028, source copy `cardio:ctgov-nct02472028-2026-10-29`, retrieved 2026-10-31)
- Countries: France (ClinicalTrials.gov record NCT02472028, source copy `cardio:ctgov-nct02472028-2026-10-29`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02472028-2026-10-29`, retrieved 2026-10-31)

## The registry's words

- Brief title: Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals
- Acronym: LEOPOLD
- Condition: Cerebrovascular Disorders
- Intervention (Other): blood pressure lowering algorithm
- Intervention (Other): usual strategy
- Lead sponsor: Assistance Publique - Hôpitaux de Paris
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Assistance Publique - Hôpitaux de Paris (`cardio:org-assistance-publique-hopitaux-de-paris`)

## Provenance

Content hash: 041f77b0b84bf55e3c7ec6cc99e8d9936f36a651514c299a1d76af93cb05614b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
